{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:01:15Z","timestamp":1762542075998},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/mjt.0b013e318255bc07","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T19:18:40Z","timestamp":1342811920000},"page":"e110-e116","source":"Crossref","is-referenced-by-count":9,"title":["Hormonal Secretion and Quality Of Life in Nelson Syndrome and Cushing Disease After Long Acting Repeatable Octreotide"],"prefix":"10.1097","volume":"21","author":[{"given":"Alejandro L.","family":"Arregger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela M. L.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga B.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elida G.","family":"Monardes Tumilasci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana N.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210202","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jcem-40-6-1125","article-title":". Inhibition by somatostatin of ACTH secretion in Nelsons syndrome.","volume":"40","author":"Tyrrell","year":"1975","journal-title":"Clin Endocrinol Metab"},{"key":"R2-18-20210202","doi-asserted-by":"crossref","first-page":"74","DOI":"10.17925\/EE.2008.04.02.74","article-title":"Medical therapy for cushings diseasepast and future modes of treatment.","volume":"4","author":"Alexandraki","year":"2008","journal-title":"Eur Endocrinol"},{"issue":"Suppl 1","key":"R3-18-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000314296","article-title":"Role of somatostatin receptors in normal and tumoral pituitary corticotropic cells.","volume":"92","author":"Hofland","year":"2010","journal-title":"Neuroendocrinology"},{"key":"R4-18-20210202","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and its receptor family.","volume":"20","author":"Patel","year":"1999","journal-title":"Front Neuroendocrinol"},{"key":"R5-18-20210202","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1210\/endo.136.11.7588261","article-title":"Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary.","volume":"136","author":"OCarroll","year":"1995","journal-title":"Endocrinology"},{"key":"R6-18-20210202","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nrd1255","article-title":". Opportunities in somatostatin research: biological, chemical and therapeutic aspects.","volume":"2","author":"Weckbecker","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"R7-18-20210202","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/eje.1.01876","article-title":". The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.","volume":"152","author":"Hofland","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R8-18-20210202","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1530\/acta.0.1200760","article-title":"The effect of the longacting somatostatin analogue SMS 201-995 on ACTH secretion in Nelsons syndrome and Cushings disease.","volume":"120","author":"Lamberts","year":"1989","journal-title":"Acta Endocrino (Copenh)"},{"key":"R9-18-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03347703","article-title":". Longterm treatment of Nelsons syndrome by octreotide: a case report.","volume":"17","author":"Petrini","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"R10-18-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/pgmj.72.843.53","article-title":". The effects of octreotide in a patient with Nelsons syndrome.","volume":"72","author":"Kelestimur","year":"1996","journal-title":"Postgrad Med J"},{"key":"R11-18-20210202","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2265.2001.01187.x","article-title":". Management of Nelsons syndrome: observations in fifteen patients.","volume":"54","author":"Kemink","year":"2001","journal-title":"Clin Endocrinol"},{"key":"R12-18-20210202","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2265.1990.tb00867.x","article-title":". Treatment of Cushing syndrome with the longacting somatostatin analogue SMS 201-995 (somatostatin).","volume":"32","author":"Invittl","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R13-18-20210202","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF03349555","article-title":". Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotrophin hypersecretion.","volume":"13","author":"Ambrosi","year":"1990","journal-title":"J Endocrinol Invest"},{"key":"R14-18-20210202","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/eje.0.1300125","article-title":". Octreotide exerts different effects in vivo and in vitro in Cushings disease.","volume":"130","author":"Stalla","year":"1994","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"R15-18-20210202","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0026-0495(96)90107-9","article-title":"Somatostatin analogs in ectopic corticotropin production.","volume":"45","author":"Von WerderK K, Muller","year":"1996","journal-title":"Metabolism"},{"key":"R16-18-20210202","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0029-1211252","article-title":". Successful treatment of ectopic Cushings syndrome with the long acting somatostatin analog octreotide.","volume":"101","author":"Rosa","year":"1993","journal-title":"Exp Clin Endocrinol"},{"key":"R17-18-20210202","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2005-1058","article-title":". Long-Term impaired Quality of Life in Cushings Syndrome despite initial improvement after surgical remission.","volume":"91","author":"Lindsay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-18-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1157\/13074369","article-title":". El cuestionario de salud SF-36 espanol: una decada de experiencia y nuevos desarrollos.","volume":"19","author":"Villagut","year":"2005","journal-title":"Gac Sanit"},{"key":"R20-18-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01468882","article-title":". Somatostatin: a potent inhibitor of ACTH hypersecretion in adrenal insufficiency.","volume":"54","author":"Fehm","year":"1976","journal-title":"Klin Wochenschr"},{"key":"R21-18-20210202","first-page":"68","article-title":". Effects of somatostatin and bromocryptine on the plasma ACTH level in bilaterally adrenalectomized patients with Cushings disease.","volume":"76","author":"Julesz","year":"1980","journal-title":"Endokrinologie"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045391-201407000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:42:51Z","timestamp":1618036971000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201407000-00018"}},"subtitle":["A Short Series and Update"],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e318255bc07","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}